EP 1420022 A1 20040519 - Use of substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
Title (en)
Use of substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
Title (de)
Verwendung von substituierten Pyridino pentaaazamykrozyklen Komplexen mit Superoxiddismutaseaktivität
Title (fr)
Utilisation de complexes de pyridinopentaazamacrocycle substitués à activité de superoxyde dismutase
Publication
Application
Priority
- EP 00966722 A 20000914
- US 39812099 A 19990916
Abstract (en)
The present invention relates to compounds which are effective as catalysts for dismutating superoxide and, more particularly, the manganese or iron complexes of substituted, unsaturated heterocyclic pentaazacyclopentadecane ligands which catalytically dismutate superoxide. <CHEM>
IPC 1-7
IPC 8 full level
C07D 487/22 (2006.01); A61K 31/44 (2006.01); A61K 31/555 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 7/02 (2006.01); A61P 9/02 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 17/06 (2006.01); A61P 19/02 (2006.01); A61P 25/04 (2006.01); A61P 25/36 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 37/06 (2006.01); A61P 39/00 (2006.01); A61P 39/06 (2006.01); B01J 31/22 (2006.01); C07D 471/00 (2006.01); C07D 471/06 (2006.01); C07D 471/08 (2006.01); C07F 13/00 (2006.01)
CPC (source: EP US)
A61K 31/555 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/02 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/36 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); A61P 37/06 (2017.12 - EP); A61P 39/00 (2017.12 - EP); A61P 39/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 471/06 (2013.01 - EP US); C07D 471/08 (2013.01 - EP US); C07F 13/005 (2013.01 - EP US); Y02A 50/30 (2017.12 - EP US)
Citation (search report)
- [A] WO 9858636 A1 19981230 - SEARLE & CO [US], et al
- [PX] UDIPI K ET AL: "Modification of inflammatory response to implanted biomedical materials in vivo by surface bound superoxide dismutase mimics", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, WILEY, NEW YORK, NY, US, vol. 51, no. 4, 2000, pages 549 - 560, XP002255242, ISSN: 0021-9304
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0119823 A2 20010322; WO 0119823 A3 20010907; WO 0119823 A9 20020926; AT E268774 T1 20040615; AT E366254 T1 20070715; AT E368039 T1 20070815; AU 7702400 A 20010417; AU 784078 B2 20060202; CA 2382105 A1 20010322; CA 2382105 C 20120110; DE 60011446 D1 20040715; DE 60011446 T2 20050707; DE 60035440 D1 20070816; DE 60035440 T2 20080313; DE 60035724 D1 20070906; DE 60035724 T2 20080430; DK 1212323 T3 20041025; EP 1212323 A2 20020612; EP 1212323 B1 20040609; EP 1420019 A1 20040519; EP 1420019 B1 20070725; EP 1420022 A1 20040519; EP 1420022 B1 20070704; ES 2222925 T3 20050216; ES 2291759 T3 20080301; ES 2293106 T3 20080316; HK 1046689 A1 20030124; HK 1046689 B 20050311; JP 2003509423 A 20030311; JP 2012097097 A 20120524; PT 1212323 E 20041029; US 6214817 B1 20010410
DOCDB simple family (application)
US 0025154 W 20000914; AT 00966722 T 20000914; AT 04003746 T 20000914; AT 04003751 T 20000914; AU 7702400 A 20000914; CA 2382105 A 20000914; DE 60011446 T 20000914; DE 60035440 T 20000914; DE 60035724 T 20000914; DK 00966722 T 20000914; EP 00966722 A 20000914; EP 04003746 A 20000914; EP 04003751 A 20000914; ES 00966722 T 20000914; ES 04003746 T 20000914; ES 04003751 T 20000914; HK 02108379 A 20021119; JP 2001523400 A 20000914; JP 2011269121 A 20111208; PT 00966722 T 20000914; US 39812099 A 19990916